Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Szela Mary T. Director active across 2 companies, notably Prometheus Biosciences, Inc.. Cumulatively, 8 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €82k. Activity tracked since 19 May 2023. The latest transaction was filed on 18 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.